Vaughan, Ontario–(Newsfile Corp. – April 29, 2024) – Delota Corp. (CSE: NIC) (FSE: S62) (“Delota” or the “Company“) a leading Canadian omni-channel retailer of nicotine-based products is pleased to announce the continued expansion of its nicotine-based product portfolio, in line with its strategic objectives for 2024.
On April 23, 2024, Delota entered into a partnership with GN Canada, the exclusive Canadian distributor of Siberia White Snus pouches, and a partner with global snus leader GN Tobacco. Based in Sweden, GN Tobacco continues to lead the industry with globally recognized brands in the nicotine pouch category.
Snus is a smokeless tobacco product that originated in Sweden. White Snus is 99% tobacco-free and represents the evolution of products in this category. Snus and White Snus are available in small pouches that users place under their upper lip, and are often used as an alternative to smoking cigarettes or other tobacco products.
Delota has noted significant rise in the popularity of the nicotine pouch category within Canada, indicating growing market demand. Siberia, a world-renowned, high-quality snus brand from Sweden, has now launched their category leading White Snus range in Canada. This product line was specifically crafted to cater to the preferences of Canadian consumers and is produced from GN Tobccao’s factory in Enköping, Sweden.
The Company recognizes the importance and value of product diversification and aims to broaden its product offerings to cater to adult users seeking alternatives to combustible tobacco as well as recreational adult users interested in exploring new product formats.
Cameron Wickham, CEO of Delota commented, “Our goal is to be one of the largest retailers of nicotine-based products nationally, and we are extremely pleased to continue executing on our strategic priorities by adding oral nicotine pouches to our product line. We are committed to partnering with brands that provide high-quality and compliant products tailored for the Canadian market. Over the last 6 months, we have engaged in strategic discussions with the GN Canada team to ensure a successful collaboration and execution in retailing the Siberia product line through our e-commerce platform in Ontario. Once rolled out across Ontario, we intend to broaden our distribution across Canada.”
Brad Jemmett, Canadian Commercial Director of GN Canada commented, “Delota is a dominant force in the Canadian nicotine product market, so partnering with them was a natural and obvious fit. Over the last year, we have seen a significant increase in the popularity of our Siberia White Snus product line, and it makes perfect sense to partner with a well-established retailer like Delota’s 180 Smoke Vape Store to further penetrate the Canadian market, specifically Ontario. We’re here to provide Canadians with the best smoking alternative products on the market. The category may be new to some, but for those who have been around White Snus pouches know the benefits of a discreet and convenient option to get nicotine satisfaction, and we’re excited to introduce that to the ritual of adult users. We are looking forward to enhancing our partnership with Delota in the near future as the category continues to expand.”
About GN Tobacco
Established in Sweden back in 2004, GN Tobacco has expanded to become a global leader in the production of snus and white snus. The company remains a family run business, committed to pioneering new approaches within the industry and catering to the needs of its vast clientele worldwide. With a new focus on Canada, GN Tobacco is showcasing its production expertise in concert with the new Canadian team of GN Canada to develop a specific portfolio aligned to Canadian consumer tastes.
Spearheading the launch of GN Canada is a team well versed in snus, vape, and alternative nicotine products. The core group of the team has been active and leading the commercialization of alternative nicotine products since 2008.
About Delota Corp.
Delota Corp. is a nicotine vape enterprise that spearheads the smoke-free revolution in Canada, catering to adult consumers seeking alternative to traditional combustible tobacco. With a strong emphasis on delivering exceptional retail experiences and carefully curated product offerings, the Company is dedicated to redefining the way people transition away from smoking. The Company’s flagship brand, 180 Smoke Vape Store, stands as Ontario’s largest specialty omnichannel vape retailer, fueling innovation, growth, and leadership in the retail vape space.
Investors interested in learning more about Delota can visit www.delota.com.
For further information, please contact:
Delota Corp.
Julia Becker
Capital Markets
T: (604) 785-0850
E: ir@delota.com
Cameron Wickham
Executive Vice Chair and CEO
T: (905) 330-1602
E: info@delota.com
Cautionary Statements
This press release contains “forward-looking statements or information”. Forward-looking statements can be identified by words such as: anticipate, intend, plan, goal, seek, believe, project, estimate, expect, strategy, future, likely, may, should, will and similar references to future periods. Examples of forward-looking statements in this press release include statements we make regarding information about future plans, expectations and objectives of the Company overall.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. The Company may not actually achieve its plans, projections, or expectations. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the adequacy of our cash flow and earnings, the availability of future financing and/or credit, developments and changes in laws and regulations, consumer sentiment towards the Company’s products, failure of counterparties to perform their contractual obligations, government regulations, competition, loss of key employees and consultants, and general economic, market or business conditions, the impact of technology and social changes on the products and industry, as well as those risk factors discussed or referred to in disclosure documents filed by the Company with the securities regulatory authorities in certain provinces of Canada and available at www.sedarplus.ca. Given these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable securities laws, we undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/207167
To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added…
eClinicalWorks and the AI medical scribe assist the 126-provider health center in completing documentation at…
INDIANAPOLIS, Nov. 22, 2024 /PRNewswire/ -- Health centers across the state of Indiana have joined…
SHENZHEN, China, Nov. 22, 2024 /PRNewswire/ -- The 19th Annual Meeting of the International Conference…
CAMBRIDGE, Mass., Nov. 22, 2024 /PRNewswire/ -- SurgiBox, a pioneer in ultra-portable, inflatable surgical environments…
FORT WORTH, Texas, Nov. 22, 2024 /PRNewswire/ -- ESHA, Inc ("ESHA") provide certain revenue cycle…